Exelixis (EXEL) Q1 2024 Earnings Call Transcript
EXEL earnings call for the period ending March 31, 2024.
Source: fool.com
📰 Jay Olson News
Jay Olson News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Jay Olson. Real-time updates on events, politics, business and more.
Biogen (BIIB) Q1 2024 Earnings Call Transcript
BIIB earnings call for the period ending March 31, 2024.
United States Czech Republic Mike Mcdonnell Piper Sandler Chris Viehbacher Salveen Richter Goldman Sachs
Source: fool.com
Global phenomenon 'Jesus Christ Superstar' to be featured at Pollard Theatre Center this week
‘Jesus Christ Superstar‘ isn’t your typical gospel show. It is a sung-through rock opera that has taken the world by storm for over 50 years, and it’s coming to Pollard
Source: tylerpaper.com
Viking Therapeutics Stock Has 72% Upside, According to 1 Wall Street Analyst
The company's experimental new weight-management drug looks great so far.
Source: yahoo.com
Viking Therapeutics Stock Has 72% Upside, According to 1 Wall Street Analyst
The company's experimental new weight-management drug looks great so far.
Source: fool.com
Why Viking Therapeutics Stock Was Rocketing Higher This Week
Good news from the lab and subsequent price target lifts by analysts put some zip into the company's shares.
Oppenheimer Jay Olson Viking Therapeutics Jay Olson Motley Fool Stock Advisor Stock Advisor Stock Advisor
Source: yahoo.com
REX American Resources Reports Upbeat Earnings, Joins Avalo Therapeutics, RH And Other Big Stocks Moving Higher On Thursday - REX American Resources (NYSE:REX)
U.S. stocks were slightly higher, with the S&P 500 gaining around 0.1% on Thursday. Shares of REX American Resources Corporation (NYSE: REX) rose sharply during Thursday’s session following upbeat quarterly earnings.
Source: benzinga.com
Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session - Akanda (NASDAQ:AKAN), Abits Group (NASDAQ:ABTS)
Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss. Kodiak Sciences posted a quarterly loss of $1.13 per share, compared to market expectations for a loss of 77 cents per share.
Nikola Corporation Jay Olson Microstrategy Incorporated Sutro Biopharma Chemours Company Avalo Therapeutics Inc
Source: benzinga.com
Cognition Therapeutics, Inc. (NASDAQ:CGTX) Q4 2023 Earnings Call Transcript
Operator: Hello, everyone, and welcome to Cognition Therapeutics Fourth Quarter 2023 Earnings Call. Please note that this call is being recorded.
Source: insidermonkey.com
Oppenheimer & Co. Inc. Announces 34th Annual Healthcare Life Sciences Conference
/PRNewswire/ -- Oppenheimer & Co. Inc. (Oppenheimer) — a leading investment bank, wealth manager and a subsidiary of Oppenheimer Holdings (NYSE: OPY) — today...
Source: prnewswire.com